Slide Kits

  


Please download the latest version of Adobe Flash Player here


Efficacy and safety profile of insulin detemir in paediatric patients with type 1 diabetes

Explore the key results from Thalange and colleagues' study investigating insulin detemir or NPH in a subgroup of patients aged 2-5 years. Discover more results from the full cohort aged up to 16 years.

Added: 20/12/11

Related Tags: basal, insulin therapy, patient, paediatrics



LEAD 1: liraglutide plus SU vs TZD plus SU

A 26-week, double-blind, placebo- and active-controlled, parallel-group trial showing efficacy and safety of liraglutide.

Added: 20/12/11

Related Tags: oral antidiabetic, treatment, weight, liraglutide



LEAD 2: demonstrating liraglutide as an add-on to an OAD

A 26-week, double-blind, placebo- and active-controlled, parallel-group multicentre study showing HbA1c reductions. The study compared the efficacy and safety of liraglutide, metformin and placebo, all in combination with SU, in type 2 diabetes.

Added: 20/12/11

Related Tags: oral antidiabetic, GLP-1, liraglutide



LEAD 3 second-year extension: liraglutide monotherapy vs SU monotherapy

A 52-week, open-label extension study of LEAD 3, comparing liraglutide with an SU in patients with type 2 diabetes. The study demonstrated that more patients achieved control with liraglutide.

Added: 20/12/11

Related Tags: GLP-1, liraglutide, patient, hypoglycaemia



LEAD 4: adding liraglutide to a combination of metformin and TZD

A 26-week, double-blind, placebo-controlled, parallel-group, multicentre study that found blood pressure reductions when comparing the efficacy of liraglutide plus metformin and TZD vs metformin plus TZD.

Added: 20/12/11

Related Tags: weight, GLP-1, HbA1c, metformin, TZD



The combination of liraglutide, metformin and SU vs the combination of basal insulin, metformin and SU

A 26-week, parallel-group, placebo-controlled, multicentre, multinational study to compare the safety and efficacy of liraglutide with self-titrated insulin in patients with type 2 diabetes not adequately controlled on metformin and SU.

Added: 20/12/11

Related Tags: weight, basal, insulin, HbA1c, metformin



LEAD 6: comparing GLP-1 agonists

Effect on glycæmic control of GLP-1 agonists in combination with metformin, sulphonylurea, or both in patients with type 2 diabetes.

Added: 20/12/11

Related Tags: GLP-1, liraglutide, glycaemic



Talking to your patients about basal-bolus therapy

How to improve your patients ' compliance, through their understanding of treatment intensification, by following these simple steps in conversation.

Added: 20/07/2011

Related Tags: basal, bolus, type 2, rapid- acting, insulin, HbA1 c



Prescribing a Rapid-Acting Insulin

Discover how adding a rapid-acting insulin to your patients' therapy may help them achieve and maintain better glycaemic control.

Added: 20/07/2011

Related Tags: insulin therapy, rapid acting insulin, bolus insulin



The Evolution of FlexPen®: Innovation in Insulin Delivery

Read about the evolution of a prefilled insulin pen.

Added: 18/10/2010

Related Tags: accuracy, aspart, biphasic, device, insulin, needle, patient, pen, premix, flexpen, novotwist



NovoPen® 4: A Step Closer to Perfection

Find out about the evolution of a durable insulin pen.

Added: 18/10/2010

Related Tags: accuracy, device, insulin, needle, novopen 4, pen, novotwist



Dose Force Review Slide Kit

Summary of three published studies comparing the injection forces of two prefilled insulin pens.

Added: 17/03/2010

Related Tags: insulin, needle, pen, flexpen



GLP-1 Analogue Slide Presentation

Overview on GLP-1 analogue therapy for the treatment of type 2 diabetes, including discussion of the incretin effect and an extensive clinical study programme investigating the use of GLP-1 analogue as add-on treatment.

Added: 17/03/2010

Related Tags: GLP-1, incretin, insulin, liraglutide, treatment, type 2



Summary of LEAD (Liraglutide Effect and Action in Diabetes) 1–6 trials

The purpose of the LEAD programme is to compare liraglutide directly against commonly used therapies in type 2 diabetes, except for metformin, with which it is used in combination.

Added: 12/04/2010

Related Tags: liraglutide, oral antidiabetic, type 2, weight




Experience NovoMedLink

Join NovoMedLink now to download and share educational slide kits, videos, clinical reprints and more to help you care for patients with diabetes


This page is for Healthcare Professionals only

novonordisk
© Novo Nordisk A/S all rights reserved.           2023     June 2010